SCHEMBL5202188

SCHEMBL5202188

CC(C)(C)c1ccc(S(=O)(=O)Nc2c[c]ccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.60
CA2 P00918 3/20 0.60
ALDH1A1 P00352 7/20 0.58
UQCRB P14927 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
POLB P06746 2/20 0.58
HTT P42858 2/20 0.58
MEN1 O00255 2/20 0.56
MAPT P10636 2/20 0.56
KMT2A Q03164 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C19 P33261 1/20 0.56
RORA P35398 1/20 0.55
IKBKB O14920 1/20 0.54
HDAC3 O15379 2/20 0.51
HDAC11 Q96DB2 2/20 0.51
HDAC8 Q9BY41 2/20 0.51
HDAC6 Q9UBN7 2/20 0.51
HSD17B2 P37059 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046801 0.85 FFAR1 (0.51) CA1CA2HTTMEN1MAPT
SCHEMBL3332937 0.83 CA12 (0.65) CA1CA2ALDH1A1POLBHTT
SCHEMBL12042475 0.81 ALDH1A1 (0.71) CA1CA2ALDH1A1UQCRBSMN1; SMN2
SCHEMBL965226 0.81 KEAP1 (0.66) CA1CA2ALDH1A1SMN1; SMN2POLB
SCHEMBL5041834 0.80 MEN1 (0.55) CA1CA2ALDH1A1POLBMEN1
SCHEMBL28821888 0.80 UQCRB (0.54) CA1CA2ALDH1A1UQCRBSMN1; SMN2
SCHEMBL5046841 0.80 HSD17B2 (0.55) CA1CA2ALDH1A1SMN1; SMN2HTT
SCHEMBL751419 0.80 CYP19A1 (0.63) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL10774342 0.80 KMT2A (0.65) CA1CA2ALDH1A1HTTMEN1
SCHEMBL5040134 0.79 ALDH1A1 (0.50) CA1CA2ALDH1A1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802572-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE Bayer Schering Pharma Aktiengesellschaft (DE) 2007-07-04 EP disclosed
WO-2006032541-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-03-30 WO disclosed